Vigabatrin Hydrochloride

• CAT Number: I001497
• CAS Number: 1391054-02-6
• Molecular Formula: C6H12ClNO2
• Molecular Weight: 165.62
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: 10 mM in DMSO
• Storage: -20°C
• IUPAC Name: 4-aminohex-5-enoic acid;hydrochloride
• InChI: InChI=1S/C6H11NO2.ClH/c1-2-5(7)3-4-6(8)9;/h2,5H,1,3-4,7H2,(H,8,9);1H
• InChIKey: FBNKOYLPAMUOHS-UHFFFAOYSA-N
• SMILES: C=CC(CCC(=O)O)N.Cl

Vigabatrin hydrochloride（Cat No.:I001497）is a medication primarily used in the treatment of epilepsy, particularly for drug-resistant partial seizures and infantile spasms. It works by inhibiting the enzyme GABA transaminase, which is responsible for the breakdown of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. By increasing GABA levels in the brain, vigabatrin enhances inhibitory neurotransmission, helping to control seizure activity. Despite its efficacy, vigabatrin is associated with potential side effects, including irreversible vision loss, and its use is typically reserved for patients who have not responded to other treatments. Regular eye monitoring is recommended during therapy.